From: Sex differences in cancer survival in Estonia: a population-based study
Men | Women | |||||
---|---|---|---|---|---|---|
5-year RSR (95% CI) | 5-year RSR (95% CI) | Difference, 1995–2000* | Difference, 2001–2006* | |||
Cancer site | 1995–2000 | 2001–2006 | 1995–2000 | 2001–2006 | ||
Mouth, pharynx | 28 (22–34) | 32 (26–37) | 48 (40–56) | 56 (48–63) | 20** | 24** |
Stomach | 20 (18–23) | 20 (18–23) | 23 (20–25) | 24 (21–27) | 3 | 4 |
Colon | 52 (47–57) | 47 (43–51) | 49 (46–52) | 53 (49–56) | −3 | 6 |
Rectum | 38 (33–42) | 46 (42–50) | 39 (35–43) | 52 (48–56) | 1 | 6 |
Pancreas | 5 (3–8) | 4 (3–7) | 7 (4–10) | 4 (3–7) | 2 | 0 |
Lung | 7 (6–9) | 10 (9–12) | 13 (10–16) | 16 (13–19) | 6** | 6** |
Skin melanoma | 58 (50–66) | 56 (49–62) | 72 (66–76) | 75 (70–79) | 14 | 19** |
Kidney | 54 (48–60) | 54 (49–59) | 58 (52–62) | 67 (62–71) | 4 | 13** |
Bladder | 62 (57–67) | 63 (59–67) | 64 (57–70) | 66 (59–72) | 2 | 3 |